Skip to main content
Glama

Findymail

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations only declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint false. The description goes far beyond this: it details internal cascading lookups, graceful degradation when GLEIF/OpenFIGI are unavailable, and explicit behavior such as returning `figi_candidates` on ambiguous matches and placing unresolved identifiers under `unresolved`. It also discloses that certain securities (non-equity) resolve here, and that ISINs map to legal entities. This rich behavioral transparency is fully consistent with annotations and adds substantial value.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but extremely well-structured: it opens with query examples and a priority instruction, then breaks down supported types with clear sub-bullets, and even includes a parameter-specific gotcha. No sentence is filler; every clause adds operational value. The structure front-loads the most critical usage guidance (when to use) and progressively details edge cases. It earns its length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (multiple entity types, multiple external sources, ambiguous matches, graceful fallbacks), the description covers all necessary aspects: supported input formats, output contents ('figi_candidates', 'unresolved', source labelling), failure modes, and performance implications (replaces 2-3 manual lookups). There is no output schema, so the description adequately explains what the agent can expect. An agent has everything needed to call this correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already describes both parameters at 100% coverage, but the description adds crucial semantic depth. For `value`, it explains that for bonds the issuer name must be passed exactly as printed and warns that trailing security-class words match nothing—critical detail not in the schema. For `type`, it details what each type returns (CIK, LEI, FIGI, RxCUI) and the sources. This transforms the parameter understanding from basic to operationally precise.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb ('resolve') and resource ('user-spoken NAME to canonical/official identifiers'), with concrete example queries ('What's the ticker for…', 'find the CIK for…'). It clearly positions this tool as the identifier-resolution entry point, distinct from siblings like compare_entities or entity_profile by saying 'Use FIRST whenever you have a name but need an ID.' This makes the purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs when to use: 'Use FIRST whenever you have a name but need an ID.' It also provides scenarios for each supported type (company, drug) and explains edge cases like bonds that never have a ticker, and the correct behavior for issuer names that match multiple instruments. While it doesn't list exclusions, the instruction to use 'FIRST' implies it precedes other tools. This is clear, actionable guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Findymail toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx and ask_pipeworx_beta are currently identical, deep_research/validate_claim/ask_pipeworx all route factual questions to the same underlying catalog, and ai_visibility_check is essentially wrapped by scan_competitor_ai_presence. The long descriptions help, but the boundaries between query, research, and verification tools are genuinely ambiguous.

Naming Consistency2/5

Names are all lowercase snake_case, but there is no consistent verb_noun or domain pattern: ask_pipeworx, findymail_find_email, scan_competitor_ai_presence, polymarket_kalshi_spread, and generate_llms_txt each use a different structural convention. The mix of brand prefixes, domain prefixes, and bare commands makes the naming feel ad hoc rather than systematic.

Tool Count2/5

33 tools is well over the 25+ threshold and reflects a server that bundles at least five distinct concerns: email lookup, structured data research, prediction-market analysis, subscriptions, and memory. Most individual tools earn their place, but the count is too high for coherent tool selection in a single MCP server.

Completeness3/5

Coverage is broad and mostly self-sufficient for the Pipeworx data ecosystem: querying, deep research, entity resolution, comparisons, verification, subscriptions, memory, and one-off utilities are all present. There are notable gaps though—there is no tool to fetch a full record from a returned pipeworx:// citation URI, and the Findymail side is limited to find/reverse with no verification or bulk capability.

Resources